(Q41434360)

30 September 2017

title

Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

26 April 2023

author name string

S. Lal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A420037

26 April 2023

N. P. Nair

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A420037

26 April 2023

P. Cervantes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A420037

26 April 2023

J. Pulman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A420037

26 April 2023

H. Guyda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A420037

26 April 2023

language of work or name

English

0 references

publication date

1 February 1979

1 reference

full work available at URL

30 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1979.tb06959.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1979.tb06959.x/fullpdf

26 April 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Acta Psychiatrica Scandinavica

26 April 2023

published in

1 reference

30 September 2017

volume

59

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

173-179

1 reference

Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Leu-enkephalin-stimulated growth hormone and prolactin release in the rat: comparison with the effect of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Intravenous Naloxone Administration in Schizophrenia and Affective Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Prolactin secretion, a measurable central effect of opiate-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Regulation of prolactin release by endogenous opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

A radioimmunoassay for human prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Lack of effect on naloxone on schizophrenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Effect of apomorphine on human-growth-hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Antipsychotic drug doses and neuroleptic/dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin--evidence for regulation by an endogenous opioid peptide in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Naloxone inhibition of stress-induced increase in prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Naloxone in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1979.TB06959.X

Indication of an Antipsychotic Action of the Opiate Antagonist Naloxone

21 January 2018

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Naloxone in heroin dependence

26 April 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Biosynthesis of Human Growth Hormone and Prolactin

26 April 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Naloxone-induced reversal of schizophrenic hallucinations

26 April 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men

26 April 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Apomorphine and psychopathology

26 April 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum

26 April 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Inhibition by Apomorphine of Prolactin Secretion in Patients with Elevated Serum Prolactin

26 April 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Interactions between naloxone and chlorpromazine on behavior under schedule control

26 April 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

An oral opiate antagonist in chronic schizophrenia: a pilot study

26 April 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats

26 April 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

26 April 2023

30

Nair N. P. V.

1978

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

Effects of naloxone on auditory hallucinations

26 April 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

26 April 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1979.TB06959.X

26 April 2023

Identifiers

1 reference

release_s6md4heiq5db7npkhyrvfogcau

30 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s6md4heiq5db7npkhyrvfogcau

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference